SEC Filings

SEC Filings
Home / SEC Filings

SEC Filings

Form 10-Q
PROTALIX BIOTHERAPEUTICS, INC. filed this Form 10-Q on 11/07/2018
Document Outline
Entire Document (1780.1 KB)
Subdocument 1 - 10-Q - FORM 10-Q
Page 1 - UNITED STATES
Page 2 - N/A
Page 3 - CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
Page 4 - N/A
Page 5 - PART I FINANCIAL INFORMATION
Page 6 - PROTALIX BIOTHERAPEUTICS, INC.
Page 7 - PROTALIX BIOTHERAPEUTICS, INC.
Page 8 - PROTALIX BIOTHERAPEUTICS, INC.
Page 9 - PROTALIX BIOTHERAPEUTICS, INC.
Page 10 - PROTALIX BIOTHERAPEUTICS, INC.
Page 11 - PROTALIX BIOTHERAPEUTICS, INC.
Page 12 - PROTALIX BIOTHERAPEUTICS, INC.
Page 13 - PROTALIX BIOTHERAPEUTICS, INC.
Page 14 - PROTALIX BIOTHERAPEUTICS, INC.
Page 15 - PROTALIX BIOTHERAPEUTICS, INC.
Page 16 - Overview
Page 17 - N/A
Page 18 - Critical Accounting Policies
Page 19 - Nine months ended September 30, 2018 compared to the nine months ended September 30, 2017
Page 20 - Liquidity and Capital Resources
Page 21 - Effects of Inflation and Currency Fluctuations
Page 22 - Currency Exchange Risk
Page 23 - N/A
Page 24 - PART II OTHER INFORMATION
Page 25 - N/A
Page 26 - N/A
Page 27 - N/A
Subdocument 2 - EX-10.1 - EXHIBIT 10.1
Page 1 - Portions of this exhibit have been omitted pursuant to a request for confidential treatment pursuant
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - N/A
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - N/A
Page 27 - N/A
Page 28 - N/A
Page 29 - [***] Redacted pursuant to confidential treatment request.
Page 30 - N/A
Page 31 - N/A
Page 32 - N/A
Page 33 - N/A
Page 34 - N/A
Page 35 - N/A
Page 36 - N/A
Page 37 - N/A
Page 38 - N/A
Page 39 - N/A
Page 40 - N/A
Page 41 - N/A
Page 42 - N/A
Page 43 - N/A
Page 44 - N/A
Page 45 - N/A
Page 46 - N/A
Page 47 - N/A
Page 48 - N/A
Page 49 - N/A
Page 50 - N/A
Page 51 - N/A
Page 52 - N/A
Page 53 - N/A
Page 54 - N/A
Page 55 - N/A
Page 56 - N/A
Page 57 - N/A
Page 58 - N/A
Page 59 - N/A
Page 60 - N/A
Page 61 - N/A
Page 62 - N/A
Page 63 - N/A
Page 64 - N/A
Page 65 - N/A
Page 66 - N/A
Page 67 - N/A
Page 68 - N/A
Page 69 - N/A
Page 70 - N/A
Page 71 - N/A
Page 72 - N/A
Page 73 - N/A
Page 74 - N/A
Page 75 - N/A
Page 76 - N/A
Page 77 - N/A
Page 78 - N/A
Page 79 - N/A
Page 80 - N/A
Page 81 - N/A
Page 82 - N/A
Page 83 - N/A
Page 84 - N/A
Page 85 - N/A
Page 86 - N/A
Page 87 - N/A
Page 88 - N/A
Page 89 - N/A
Page 90 - N/A
Page 91 - Schedule 3.1 Development Plan
Page 92 - Schedule 3.7 Initial Draft Commercialization Plan
Page 93 - Schedule 5.3(i) Example of Development Cost Detail
Page 94 - Schedule 7.1(b) Specified Patent Applications
Page 95 - Exhibit A Protalix Patent Rights
Page 96 - Exhibit B Third Party Licenses
Page 97 - Exhibit C Press Release
Page 98 - About Protalix BioTherapeutics, Inc.
Page 99 - Forward-Looking Statements
Page 100 - Investor Contact
Page 101 - Exhibit D Chiesi Anti-Bribery Policy
Page 102 - Exhibit E Chiesi Code of Ethics and Conduct
Subdocument 3 - EX-31.1 - EXHIBIT 31.1
Page 1 - N/A
Subdocument 4 - EX-31.2 - EXHIBIT 31.2
Page 1 - N/A
Subdocument 5 - EX-32.1 - EXHIBIT 32.1
Page 1 - N/A
Subdocument 6 - EX-32.2 - EXHIBIT 32.2
Page 1 - N/A
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE (What's this?)
XBRL Viewer